These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25537460)

  • 1. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.
    Li H; Yu X; Cicala MV; Mantero F; Benbrook A; Veitla V; Cunningham MW; Kem DC
    J Am Soc Hypertens; 2015 Jan; 9(1):15-20. PubMed ID: 25537460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
    Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
    J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
    Williams TA; Jaquin D; Burrello J; Philippe A; Yang Y; Rank P; Nirschl N; Sturm L; Hübener C; Dragun D; Bidlingmaier M; Beuschlein F; Reincke M
    Hypertension; 2019 Oct; 74(4):784-792. PubMed ID: 31476909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
    Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
    Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
    Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
    Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism.
    Meyer LS; Gong S; Reincke M; Williams TA
    Horm Metab Res; 2020 Jun; 52(6):379-385. PubMed ID: 32168525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.
    Sabbadin C; Ceccato F; Ragazzi E; Boscaro M; Betterle C; Armanini D
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1313-1318. PubMed ID: 30058103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism?
    Piazza M; Seccia TM; Caroccia B; Rossitto G; Scarpa R; Persichitti P; Basso D; Rossi GP
    Hypertension; 2019 Oct; 74(4):793-799. PubMed ID: 31476908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
    Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
    J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
    Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
    J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
    Fallo F; Chouman M; Pagotto U; Pistorello M
    Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.
    Maeda A; Okazaki T; Inoue M; Kitazono T; Yamasaki M; Lemonnier FA; Ozaki S
    Int Immunopharmacol; 2009 Sep; 9(10):1183-8. PubMed ID: 19540938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.